CJC-1295 DAC vs CJC-1295 + Ipamorelin Blend
CJC-1295 and Ipamorelin demand clusters around both component comparison and research-vial supplier intent. This page supports the Remy blend vial by clarifying component evidence and the difference between CJC-1295 DAC language and a co-formulated CJC-1295 + Ipamorelin research vial.
Update History ▾
Research-use-only framing applied throughout in line with Remy editorial standards.
CJC-1295 and Ipamorelin demand clusters around both component comparison and research-vial supplier intent. This page supports the Remy blend vial by clarifying component evidence and the difference between CJC-1295 DAC language and a co-formulated CJC-1295 + Ipamorelin research vial. Remy Peptides currently lists CJC-1295 + Ipamorelin 5mg/5mg Vial as In stock, with 10mg total · Lyophilized research vial and AED 500-600 pricing shown in the product catalog. This article supports the product page with evidence context, local Dubai/UAE search routing, and COA verification language only.
Why This Product-Support Guide Exists
Use the product page for the 5mg/5mg blend vial. Use this guide for the CJC-1295 DAC, CJC-1295, and Ipamorelin comparison question that precedes supplier selection.
This guide answers common local research-supply searches such as:
- buy cjc 1295 dac
- cjc ipamorelin
- cjc-1295 + ipamorelin
- cjc 1295 dubai
- buy cjc 1295 dubai
For current product facts, start with CJC-1295 + Ipamorelin 5mg/5mg Vial. This article adds the surrounding evidence, supplier-verification, and compliance context around that listing.
Evidence Map and Translation Limits
CJC-1295 is a long-acting GHRH analog studied for prolonged GH and IGF-1 secretion, while Ipamorelin is described in early literature as a selective growth-hormone secretagogue.[1][2] The blend-rationale discussion should remain a research-design concept, because published human data on the exact Remy-style co-formulated vial are limited.[3]
| Research layer | What the literature supports | How it should inform the product page |
|---|---|---|
| CJC-1295 component | The CJC-1295 literature centers on GHRH analog design, albumin-binding extension, and prolonged endocrine signal measurement. | Supports component identity for the blend page. |
| Ipamorelin component | Ipamorelin literature focuses on ghrelin-pathway secretagogue selectivity and model-level endocrine signaling. | Explains why researchers compare it with GHRH analogs. |
| Blend evidence limit | Component data do not equal clinical validation for a fixed 5mg/5mg research blend. | Prevents synergy or protocol overclaiming. |
Dubai/UAE Product Documentation
For commercial clarity, the live product page remains the source of truth. This article mirrors only stable catalog facts and points researchers back to the current listing before any order or restock check.
| Field | Current Remy Peptides listing |
|---|---|
| Product page | CJC-1295 + Ipamorelin 5mg/5mg Vial |
| Format | 10mg total · Lyophilized research vial |
| Stock status | In stock |
| AED price tier | AED 500-600 |
| COA route | Check the product page and COA library; request lot-specific HPLC documentation when a public batch file is not yet posted. |
| Use restriction | For in-vitro laboratory research only. Not for human or veterinary use. |
Supplier Checks for Research-Use Buyers
For Dubai and UAE research-supply searches, the cleanest buying checklist is evidence-light and verification-heavy. Before comparing any CJC-1295 + Ipamorelin source, confirm:
- The seller gives a stable product URL with vial size, format, price tier, and stock status.
- The page states Research Use Only and avoids human-use, veterinary-use, diagnostic, therapeutic, or disease-management claims.
- COA language is batch-specific, with HPLC purity and identity documentation available before purchase or on request.
- Cold-chain handling and official-contact verification are clear enough to reduce impersonation and gray-market risk.
Remy Peptides centralizes that workflow through the product page, the COA library, and contact verification.
What This Page Does Not Claim
The research record helps define the compound, but it does not turn an RUO vial into a clinical product. Keep these boundaries in view:
- Do not present the blend as an anti-aging, muscle, recovery, or hormone-optimization product.
- Do not include timing schedules, dosing charts, or administration routes.
- Separate DAC terminology from the exact Remy blend format.
Our Research Standards
This article was built from local non-retatrutide search-demand review, existing Remy article standards, live product-catalog data, and peer-reviewed or official source checks. No therapeutic, human-use, or veterinary-use claim is made. Read our editorial policy →
CJC-1295 + Ipamorelin Research FAQ
Can Dubai researchers buy CJC-1295 + Ipamorelin from Remy Peptides?
Yes. Remy Peptides lists CJC-1295 + Ipamorelin 5mg/5mg Vial as in stock for research-use-only orders in Dubai and the UAE. The live product page is the source of truth for current stock, AED pricing, and COA request details.
What format and price does Remy list for CJC-1295 + Ipamorelin?
Remy Peptides lists CJC-1295 + Ipamorelin as 10mg total · Lyophilized research vial, with current AED tiers shown as AED 500-600. Prices, pack tiers, and orderability can change, so the product page should be checked before any research order.
What evidence does this CJC-1295 + Ipamorelin guide cover?
This article summarizes compound identity, the strongest peer-reviewed evidence anchors, and the limits of translating regulated or preclinical findings to a research-use catalog vial. It is an evidence map, not a clinical-use guide.
Is CJC-1295 + Ipamorelin sold for human or veterinary use?
No. Remy Peptides products are supplied strictly for in-vitro laboratory research. They are not for human use, veterinary use, diagnosis, treatment, cure, disease management, or personal-use protocols.
Which page should researchers use next?
Use /product/cjc-1295-ipamorelin-5mg-5mg for the live product facts, price tier, stock status, image, and COA route. Use the linked Remy research profile or comparison article for deeper mechanism and evidence context.
Sources
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism. 2006. PMID: 16352683 ↑
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998. PMID: 9849822 ↑
- Kojima M, Kangawa K. Ghrelin: structure and function. PMC4443295 ↑
For current stock, pricing, and COA route, use the live CJC-1295 + Ipamorelin 5mg/5mg Vial page. For wider supplier verification, continue to the peptide COA guide and official contact verification.